These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 640246)

  • 1. Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabetics.
    Raskin P; Unger RH
    Diabetes; 1978 Apr; 27(4):411-9. PubMed ID: 640246
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of exogenous hyperglucagonemia in insulin-treated diabetics.
    Raskin P; Unger RH
    Diabetes; 1977 Nov; 26(11):1034-9. PubMed ID: 410690
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetes.
    Aydin I; Raskin P; Unger RH
    Diabetologia; 1977 Dec; 13(6):629-36. PubMed ID: 590654
    [No Abstract]   [Full Text] [Related]  

  • 4. Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics.
    Christensen SE; Hansen AP; Orskov H; Lundbaek K
    Metabolism; 1978 Sep; 27(9 Suppl 1):1427-31. PubMed ID: 683011
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T; Raskin P; Aydin I; Unger R
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and metabolic effects of moderate exercise in type I-diabetics with hypo- and hyperinsulinemia.
    Zander E; Schulz B; Woltansky P; Wulfert P; Chlup R
    Acta Univ Palacki Olomuc Fac Med; 1985; 111():281-6. PubMed ID: 2949507
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps.
    Raskin P; Pietri A; Unger R
    Diabetes; 1979 Nov; 28(11):1033-5. PubMed ID: 488544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous glucagon-like peptide I combined with insulin normalizes postcibal glycemic excursions in IDDM.
    Dupré J; Behme MT; Hramiak IM; McDonald TJ
    Diabetes Care; 1997 Mar; 20(3):381-4. PubMed ID: 9051391
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
    Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
    Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon and diabetes mellitus.
    Herlihy B
    Crit Care Nurse; 1983; 3(1):38-43. PubMed ID: 6402337
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
    Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
    Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hyperglucagonemia on blood glucose concentrations and on insulin requirements in insulin-requiring diabetes mellitus.
    Clarke WL; Santiago JV; Kipnis DM
    Diabetes; 1978 Jun; 27(6):649-52. PubMed ID: 658610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus.
    Raskin P; Aydin I; Unger RH
    Diabetes; 1976 Mar; 25(3):227-9. PubMed ID: 1254112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.
    Starke A; Keck E; Berger M; Zimmermann H
    Diabetologia; 1981 May; 20(5):547-52. PubMed ID: 7026328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone in insulin-treated diabetes mellitus.
    Sabeh G; Mendelsohn LV; Corredor DG; Sunder JH; Friedman LM; Morgan CR; Danowski TS
    Metabolism; 1969 Sep; 18(9):748-53. PubMed ID: 5343866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.